The role of probucol preventing contrast-induced nephropathy in patients undergoing invasive coronary procedures - Systematic review and meta-analysis of randomized controlled trials
Saved in:
Main Authors: | Raymond Pranata (Author), Emir Yonas (Author), Rachel Vania (Author), Antonia Anna Lukito (Author) |
---|---|
Format: | Book |
Published: |
KARE Publishing,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Oral Nicorandil to Prevent Contrast-Induced Nephropathy in Patients with Chronic Renal Dysfunction Undergoing an Elective Coronary Procedure
by: Zeyuan Fan, et al.
Published: (2019) -
The Effects of Pentoxifylline on Contrast-induced Nephropathy Reduction in Patients Undergoing Percutaneous Coronary Intervention
by: Mohammad Rouzbahani, et al.
Published: (2022) -
Predictors of contrast-induced nephropathy in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention
by: Mohamed Abdel-Ghany, et al.
Published: (2021) -
Role of KIM-1 in early diagnosis of contrast-induced nephropathy following invasive cardiac procedure: A systematic review
by: Mantasha Shuaib, et al.
Published: (2024) -
Remote Ischemic Preconditioning Reduces the Risk of Contrast-Induced Nephropathy in Patients with Moderate Renal Impairment Undergoing Percutaneous Coronary Angiography: A Meta-Analysis
by: Jin Deng, et al.
Published: (2020)